U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
173311173311Safety and Efficacy of Pirfenidone in Patients With Idiopathic Pulmonary FibrosisCompletedHas ResultsIdiopathic Pulmonary FibrosisDrug: Pirfenidone|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00287729
173312173312Three-Arm Study of the Safety and Efficacy of Pirfenidone in Patients With Idiopathic Pulmonary FibrosisCompletedHas ResultsIdiopathic Pulmonary FibrosisDrug: Pirfenidone|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00287716
173313173313Pulsed Electro Magnetic Fields (PEMF) Treatment in Patients With Treatment-Resistant Major Depression in Ongoing Pharmacological Treatment of DepressionCompletedNo Results AvailableDepressionDevice: Pulsating Electro-Magnetic Fields|Device: Pulsating Electro-Magnetic Fields shamhttps://ClinicalTrials.gov/show/NCT00287703
173314173314Isoflavones and the Coronary Circulation in Men and Women With Coronary Artery DiseaseCompletedNo Results AvailableCoronary Artery DiseaseDrug: genistein (Supro)https://ClinicalTrials.gov/show/NCT00287690
173315173315Induction and Expansion of T Cell Repertoire Using Growth Hormone and Vaccination in HIV-1 Infected PatientsCompletedNo Results AvailableHIV InfectionsBiological: recombinant human Growth Hormone|Biological: Vaccination|Drug: HAARThttps://ClinicalTrials.gov/show/NCT00287677
173316173316Treatment of Hepatorenal Syndrome With Terlipressin Plus Albumin vs AlbuminSuspendedNo Results AvailableCirrhosis|Hepatorenal SyndromeDrug: terlipressinhttps://ClinicalTrials.gov/show/NCT00287664
173317173317Effects of Pulsatile IV Insulin Delivery on Diabetic Retinopathy in Patients With Types 1 and 2 Diabetes MellitusTerminatedNo Results AvailableDiabetes Mellitus, With ComplicationsProcedure: Pulsatile IV Insulin|Procedure: Effects of Pulsatile IV Insulin on Diabetic Retinopathy|Procedure: Effects of Pulsatile IV Insulin on Diabetic Retinopathy|Procedure: Effects of Pulsatile IV Insulin on diabetic retinopathyhttps://ClinicalTrials.gov/show/NCT00287651
173318173318Markers in Exhaled Breath Condensate in Obstructive Sleep Apnoea (OSA) PatientsCompletedNo Results AvailableObstructive Sleep ApneaDevice: CPAP|Device: placebohttps://ClinicalTrials.gov/show/NCT00287638
173319173319Early Pulmonary Rehabilitation for Hospitalized Patients With Exacerbations of Chronic Obstructive Pulmonary Disease (COPD)CompletedNo Results AvailableChronic Obstructive Pulmonary DiseaseProcedure: Pulmonary rehabilitationhttps://ClinicalTrials.gov/show/NCT00287625
173320173320Necessity of Esophageal Dissection During Laparoscopic FundoplicationCompletedNo Results AvailableGastroesophageal Reflux Disease|Hiatal HerniaProcedure: Lap. Fundo. with Mobilization of the Esophageal Junction|Procedure: Lap. Fundo. without Mobilization of the Esophageal Junctionhttps://ClinicalTrials.gov/show/NCT00287612
173321173321Rapid Identification of Key Pathogens in Wound Infection by Molecular MeansCompletedNo Results AvailablePostoperative Wound Infection|Traumatic Wound Infection|Closed Soft Tissue Abscesshttps://ClinicalTrials.gov/show/NCT00287599
173322173322Testosterone Replacement in Older Men and Atherosclerosis ProgressionActive, not recruitingNo Results AvailableHypogonadism|AtherosclerosisDrug: Testosterone Gel (Androgel)https://ClinicalTrials.gov/show/NCT00287586
173323173323Randomized Trial Evaluating Slow-Release Formulation TAXUS Paclitaxel-Eluting Coronary Stent in the Treatment of In-Stent RestenosisCompletedNo Results AvailableCoronary RestenosisDevice: TAXUS Express2|Procedure: Brachytherapy (beta source)https://ClinicalTrials.gov/show/NCT00287573
173324173324Effect of a Modified Propofol Preparation on Injection Pain During Induction of Anesthesia in ChildrenCompletedNo Results AvailableAnesthesiaDrug: propofol (drug)https://ClinicalTrials.gov/show/NCT00287560
173325173325Phase II Randomized, Double-Blind, Placebo-Controlled Study of BMS-188667 (CTLA4Ig) in Patients With Psoriasis VulgarisCompletedNo Results AvailablePsoriasis VulgarisDrug: CTLA4Ig / Abatacepthttps://ClinicalTrials.gov/show/NCT00287547
173326173326Effectiveness of Combination of Arimidex and Nolvadex in Adjuvant Therapy of Breast Carcinoma in Postmenopausal Women.CompletedNo Results AvailableBreast CancerDrug: Anastrozole|Drug: Tamoxifenhttps://ClinicalTrials.gov/show/NCT00287534
173327173327A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular HypertensionCompletedNo Results AvailableOpen-angle Glaucoma|Ocular HypertensionDrug: AL-37807 Ophthalmic Suspension, 1.0%|Drug: Latanoprost, 0.005% (Xalatan)|Other: AL-37807 Vehicle|Drug: Timolol Maleate Ophthalmic Gel Forming Solution, 0.5%https://ClinicalTrials.gov/show/NCT00287521
173328173328Emboshield® and Xact® Post Approval Carotid Stent Trial (The EXACT Study)CompletedNo Results AvailableCarotid Artery Disease|Carotid Stenosis|Stroke|AtherosclerosisDevice: Carotid artery stenting with filter (interventional)https://ClinicalTrials.gov/show/NCT00287508
173329173329BAY 43-9006 (Sorafenib) to Treat Patients With Kaposi's SarcomaCompletedNo Results AvailableKaposi's Sarcoma|HHV-8|KSHVDrug: Nexavar (BAY 43-9006) (Sorafenib)https://ClinicalTrials.gov/show/NCT00287495
173330173330Essiac (ESIAK) Versus Placebo to Improve Quality of Life in Transition in Women With Breast or Ovarian Cancer.TerminatedNo Results AvailableOvarian Cancer|Breast CancerDrug: Essiachttps://ClinicalTrials.gov/show/NCT00287482
173331173331A Safety and Efficacy Study of the Hepatitis E Vaccine in Nepal.CompletedNo Results AvailableHepatitisBiological: Hepatitis E vaccine, recombinant (Sar 56 kDa)https://ClinicalTrials.gov/show/NCT00287469
173332173332Use of the Insulin Pump in Cystic Fibrosis Patients With Impaired Glucose Tolerance or CFRD and in Type 1 Diabetes Patients.Active, not recruitingNo Results AvailableCystic Fibrosis Related DiabetesDevice: Insulin Pump|Drug: Insulin|Procedure: Oral Glucose Tolerance Test|Procedure: Whole body Protein Turnoverhttps://ClinicalTrials.gov/show/NCT00287456
173333173333Metabolic Abnormalities in Hispanic Children With Cystic FibrosisActive, not recruitingNo Results AvailableCystic FibrosisProcedure: Oral Glucose tolerance test|Procedure: Whole body protein turnover|Procedure: IV glucose tolerance test|Procedure: Indirect Calorimetry|Procedure: Dual Energy X-ray Absorptiometry (DEXA)|Procedure: Growth Hormone Stimulation Testhttps://ClinicalTrials.gov/show/NCT00287443
173334173334Growth Hormone Use in Adolescents and Adults With Cystic FibrosisActive, not recruitingNo Results AvailableCystic FibrosisDrug: Growth Hormone|Procedure: Whole body Protein Turnover Study|Procedure: Dual Energy X-ray Absorptiometry (DEXA)https://ClinicalTrials.gov/show/NCT00287430
173335173335Early Ultrasound and Maternal Biochemical Markers to Evaluate the Risk of Down Syndrome During the First TrimesterCompletedNo Results AvailableDown SyndromeDevice: echography|Other: blood samplehttps://ClinicalTrials.gov/show/NCT00287417
173336173336Measuring Cholesterol in the Fasting and Postmeal State in Patients With Type 2 DiabetesCompletedNo Results AvailableType 2 Diabeteshttps://ClinicalTrials.gov/show/NCT00287404
173337173337Sleep Disorders and Gastroesophageal Reflux Disease (GERD)CompletedNo Results AvailableInsomnia|GERDDrug: Rabeprazolehttps://ClinicalTrials.gov/show/NCT00287391
173338173338Effect of Ozone on Airway Inflammation in Allergic Asthmatics Treated With OmalizumabTerminatedNo Results AvailableAsthma|AllergyDrug: omalizumabhttps://ClinicalTrials.gov/show/NCT00287378
173339173339Genetic Susceptibility to Ozone in Mild Asthmatic VolunteersActive, not recruitingNo Results AvailableMild AsthmaDrug: ozonehttps://ClinicalTrials.gov/show/NCT00287365
173340173340Study of Amantadine for Weight Stabilization During Olanzapine TreatmentCompletedNo Results AvailablePsychotic Disorder|Schizophreniform Disorder|Schizophrenia|Schizoaffective Disorder|Mood Disorders With Psychotic FeaturesDrug: Olanzapine, Amantadine|Drug: Olanzapine and placebohttps://ClinicalTrials.gov/show/NCT00287352

* Görseller ve İçerik tekif hakkına sahip olabilir